Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
The Musashi (MSI) family is an evolutionarily conserved RNA-binding protein that is expressed primarily in a variety of tissue stem/progenitor cells, such as the nervous system, epithelial tissue, and hematopoietic system, regulating stem cell proliferation. As a member of the MSI family, MSI2 is highly homologous to MSI1 in molecular structure. Its agreement on the amino acid sequence of the total amino acid sequence and the RNA binding domain is 75% and 90%.
Physiological Function of MSI2
The Y chromosome sex determination box 2 (Sox2) and octamer binding transcription factor 4 (Oct4) are key factors for self-renewal and differentiation of embryonic stem cells. They synergistically regulate the differentiation and development process of embryonic stem cells. The study found that MSI2 is a Sox2-related protein involved in cellular RNA processing and plays an important role in the self-renewal of embryonic stem cells. The study looked at the cytological changes of embryonic stem cells by knocking out the subtype and subtype b of MSI2. It was found that the MSI2 protein a subtype and subtype b play key roles in the self-renewal process of embryonic stem cells and indicate the expression level of MSI2 protein. Alterations can lead to imbalances in Sox2 and Oct4 and regulate embryonic stem cell proliferation, differentiation and development.
In the central nervous system, MSI2 mainly expresses neural precursor cells in the ventricle and subventricular zone, and also expresses cells in the astrocyte lineage, including ependymal cells, which are involved in the maintenance of neural stem cells. Studies have shown that Sox2 is a key transcription factor for nervous system development, and MSI2 acts as a Sox2-related protein to maintain self-renewal of undifferentiated neural stem cells. In addition, studies have found that MSI2 is still expressed in basal ganglia and in some neuronal cells of neuronal cell lines such as γ-aminobutyric acid (GABA) neuron. However, MSI2 is deleted or down-regulated in most post-mitotic neurons, suggesting that MSI2 may play an important regulatory role in specific neural cell lines.
Figure 1. RNA-binding proteins Msi1 and/or Msi2 are required for colorectal cancer. (Li, N., et al. 2015)
MSI2 and Tumor
MSI2 promotes the growth, proliferation and invasion of brain tumors. Multi-dimensional protein identification technology (MudPIT) was used to identify at least 280 Sox2-related proteins in bronchial cell tumor cell line DAOY, and MSI2 and USP9X were screened out. It was found that knocking out MSI2 and USP9X significantly inhibited medulloblastoma cells. The growth of DAOY and glioma cell lines U87 and U118 is associated with poor prognosis in patients with brain tumors. MSI2 is up-regulated in Hepatitis B virus-associated hepatocellular carcinoma, which is closely related to tumor size, tumor differentiation, recurrence, TNM stage, and vascular invasion.
Guo et al. found that MSI2 is overexpressed in pancreatic cancer cells and promotes its proliferation and migration. KLF4 gene (Krüppel-like factor 4) binds to the promoter region of MSI2 to inhibit its transcription. Therefore, the KLF4-MSI2 signal axis as a research target can provide a new strategy for preventing metastasis and diagnosis of pancreatic cancer. In addition, Yang et al. first demonstrated through experiments that silencing of MSI2 expression significantly reduced tyrosine kinase 2 (Janus Kinase 2, JAK2) and its downstream effector signal transducers and activator 3 (signal transducers) in bladder cancer cell lines. The phosphorylation level of activators of transcription1 and STAT3), while the expression of WASF3 in MSI2 overexpressing tumor cells was significantly higher than that of the control group, which was activated by JAK2/STAT3 signaling pathway to promote cell migration and invasion.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.